{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:15:22Z","timestamp":1760055322021,"version":"build-2065373602"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Deanship of Research and Graduate Studies, King Khalid University, Abha, Saudi Arabia","award":["R.G.P.2\/516\/45","R.G.P.2\/516\/45"],"award-info":[{"award-number":["R.G.P.2\/516\/45","R.G.P.2\/516\/45"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s00210-025-04218-4","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T05:00:23Z","timestamp":1745902823000},"page":"14413-14424","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hospital epidemiology and antimicrobial susceptibility of isolated methicillin-resistant Staphylococcus aureus: a 5-year retrospective study at a tertiary care centre in Aseer Region, Saudi Arabia"],"prefix":"10.1007","volume":"398","author":[{"given":"Yasser","family":"Alraey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed Mushabub","family":"Assiry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irfan","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safia Obaidur","family":"Rab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulaziz","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulah A. S.","family":"Bawazeer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarig","family":"Hussien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azharuddin Sajid","family":"Syed Khaja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2813-6279","authenticated-orcid":false,"given":"Mohd","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"issue":"3","key":"4218_CR1","doi-asserted-by":"publisher","first-page":"264","DOI":"10.9738\/INTSURG-D-13-00251.1","volume":"99","author":"FA Al-Mulhim","year":"2014","unstructured":"Al-Mulhim FA, Baragbah MA, Sadat-Ali M, Alomran AS, Azam MQ (2014) Prevalence of surgical site infection in orthopedic surgery: a 5-year analysis. Int Surg 99(3):264\u2013268","journal-title":"Int Surg"},{"key":"4218_CR2","doi-asserted-by":"publisher","unstructured":"Alsolami A, ALGhasab NS, Alharbi MSM, Bashir AI, Saleem M, Syed Khaja AS, Aldakheel DF, Rakha E, Alshammari JA, Taha TE, Melibari Z, Alharbi YH, Almutlag AA, Said KB (2023) Ha\u2019il COM Research Unit Group. Community-acquired methicillin-resistant Staphylococcus aureus in hospitals: age-specificity and potential zoonotic-zooanthroponotic transmission dynamics. Diagnostics (Basel) 16;13(12):2089. https:\/\/doi.org\/10.3390\/diagnostics13122089","DOI":"10.3390\/diagnostics13122089"},{"issue":"1","key":"4218_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/2047-2994-1-26","volume":"1","author":"M Aly","year":"2012","unstructured":"Aly M, Balkhy HH (2012) The prevalence of antimicrobial resistance in clinical isolates from Gulf Corporation Council countries. Antimicrob Resist Infect Control 1(1):26","journal-title":"Antimicrob Resist Infect Control"},{"issue":"1","key":"4218_CR4","first-page":"42","volume":"16","author":"R Amatya","year":"2014","unstructured":"Amatya R, Devkota P, Gautam A (2014) Reduced susceptibility to vancomycin in methicillin resistant staphylococcus aureus: a time for action. Nepal Med Coll J 16(1):42\u201344","journal-title":"Nepal Med Coll J"},{"key":"4218_CR5","doi-asserted-by":"publisher","unstructured":"Amoako DG, Somboro AM, Sekyere JO, Moodley K, Bester LA, Essack SY (2019) Tet(M) mediates tetracycline resistance in methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates from the private hospital sector in KwaZulu-Natal (KZN), South Africa. J Pure Appl Microbiol 13(1):51-59 https:\/\/doi.org\/10.22207\/JPAM.13.1.05","DOI":"10.22207\/JPAM.13.1.05"},{"issue":"18","key":"4218_CR6","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1080\/14656566.2019.1675637","volume":"20","author":"M Bassetti","year":"2019","unstructured":"Bassetti M, Carnelutti A, Castaldo N, Peghin M (2019) Important new therapies for methicillin-resistant Staphylococcus aureus. Expert Opin Pharmacother 20(18):2317\u20132334. https:\/\/doi.org\/10.1080\/14656566.2019.1675637","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"4218_CR7","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1128\/AAC.02251-13","volume":"58","author":"N Bourgeois-Nicolaos","year":"2014","unstructured":"Bourgeois-Nicolaos N, Nguyen TT, Defrance G, Massias L, Alavoine L, Lefort A, Noel V, Senneville E, Doucet-Populaire F, Mentr\u00e9 F, Andremont A, Duval X (2014) The emergence of linezolid resistance among Enterococci in intestinal microbiota of treated patients is unrelated to individual pharmacokinetic characteristics. Antimicrob Agents Chemother 58(5):2681\u20132687. https:\/\/doi.org\/10.1128\/AAC.02251-13","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"4218_CR8","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/MAJ.0b013e3181e95fdc","volume":"340","author":"HA Bukharie","year":"2010","unstructured":"Bukharie HA (2010) Increasing threat of community-acquired methicillin-resistant Staphylococcus aureus. Am J Med Sci 340(5):378\u2013381","journal-title":"Am J Med Sci"},{"issue":"1\u20132","key":"4218_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0732-8893(01)00242-5","volume":"40","author":"HA Bukharie","year":"2001","unstructured":"Bukharie HA, Abdelhadi MS, Saeed IA, Rubaish AM, Larbi EB (2001) Emergence of methicillin-resistant Staphylococcus aureus as a community pathogen. Diagn Microbiol Infect Dis 40(1\u20132):1\u20134","journal-title":"Diagn Microbiol Infect Dis"},{"key":"4218_CR10","unstructured":"CDC (2019) What CDC is Doing to Combat MRSA. Retrieved January 18, 2024, from https:\/\/www.cdc.gov\/mrsa\/tracking\/index.html"},{"key":"4218_CR11","unstructured":"CDC (2020) Methicillin-resistant Staphylococcus aureus: preventing Infections in Healthcare. Retrieved 03\/Nov\/2023, from https:\/\/www.cdc.gov\/mrsa\/healthcare\/inpatient.html#print"},{"issue":"9","key":"4218_CR12","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrmicro2200","volume":"7","author":"HF Chambers","year":"2009","unstructured":"Chambers HF, Deleo FR (2009) Waves of resistance: Staphylococcus aureus in the antibacterial substance era. Nat Rev Microbiol 7(9):629\u2013641. https:\/\/doi.org\/10.1038\/nrmicro2200","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"4218_CR13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/jac\/dkt340","volume":"69","author":"SY Chen","year":"2014","unstructured":"Chen SY, Liao CH, Wang JL, Chiang WC, Lai MS, Chie WC, Chang SC, Hsueh PR (2014) Method-specific performance of vancomycin MIC susceptibility tests in predicting mortality of patients with methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 69(1):211\u2013218","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"4218_CR14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1139\/W09-109","volume":"56","author":"N Cimolai","year":"2010","unstructured":"Cimolai N (2010) Methicillin-resistant Staphylococcus aureus in Canada: a historical perspective and lessons learned. Can J Microbiol 56(2):89\u2013120","journal-title":"Can J Microbiol"},{"issue":"10325","key":"4218_CR15","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"AR Collaborators","year":"2022","unstructured":"Collaborators AR (2022) Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399(10325):629\u2013655","journal-title":"Lancet"},{"key":"4218_CR16","doi-asserted-by":"publisher","unstructured":"El-Mahdy R, Mostafa A, El-Kannishy G (2018) High level aminoglycoside resistant enterococci in hospital-acquired urinary tract infections in Mansoura, Egypt. Germs 8(4):186\u2013190. https:\/\/doi.org\/10.18683\/germs.2018.1145","DOI":"10.18683\/germs.2018.1145"},{"key":"4218_CR17","unstructured":"European Centre for Disease Prevention and Control (ECDC) (2023). Antimicrobial resistance surveillance in Europe \u2013 Annual Report"},{"key":"4218_CR18","doi-asserted-by":"crossref","unstructured":"Fridkin SK, Hageman J, McDougal LK, Mohammed J, Jarvis WR, Perl TM, Tenover FC, V-ISaES Group (2003) Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997\u20132001. Clin. Infect. Dis 36(4):429\u2013439","DOI":"10.1086\/346207"},{"issue":"1","key":"4218_CR19","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1054\/drup.1998.0068","volume":"2","author":"DC Hooper","year":"1999","unstructured":"Hooper DC (1999) Mechanisms of fluoroquinolone resistance. Drug Resist Updat 2(1):38\u201355. https:\/\/doi.org\/10.1054\/drup.1998.0068","journal-title":"Drug Resist Updat"},{"issue":"4","key":"4218_CR20","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1086\/381202","volume":"38","author":"BP Howden","year":"2004","unstructured":"Howden BP, Ward PB, Charles PG, Korman TM, Fuller A, du Cros P, Grabsch EA, Roberts SA, Robson J, Read K, Bak N, Hurley J, Johnson PD, Morris AJ, Mayall BC, Grayson ML (2004) Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility. Clin Infect Dis 38(4):521\u2013528","journal-title":"Clin Infect Dis"},{"issue":"1","key":"4218_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1128\/CMR.00042-09","volume":"23","author":"BP Howden","year":"2010","unstructured":"Howden BP, Davies JK, Johnson PD, Stinear TP, Grayson ML (2010) Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. Clin Microbiol Rev 23(1):99\u2013139. https:\/\/doi.org\/10.1128\/CMR.00042-09","journal-title":"Clin Microbiol Rev"},{"key":"4218_CR22","doi-asserted-by":"crossref","unstructured":"K\u00a8ock R, Becker K, Cookson B, van Gemert-Pijnen JE, Harbarth S, Kluytmans J, Mielke M, Peters G, Skov RL, Struelens MJ, Tacconelli E, Navarro Torn\u00b4 e A, Witte W, Friedrich AW (2010) Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Surveill 15(41):19688","DOI":"10.2807\/ese.15.41.19688-en"},{"issue":"1","key":"4218_CR23","doi-asserted-by":"publisher","first-page":"584","DOI":"10.2174\/1874944501811010584","volume":"11","author":"Khalid Mohamed Adam and Mosleh Mohamed Abomughaid","year":"2018","unstructured":"Khalid Mohamed Adam and Mosleh Mohamed Abomughaid (2018) Prevalence of Methicillin-resistant Staphylococcus Aureus in Saudi Arabia revisited: a meta-analysis. Open Public Health J 11(1):584\u2013591. https:\/\/doi.org\/10.2174\/1874944501811010584","journal-title":"Open Public Health J"},{"issue":"8","key":"4218_CR24","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1093\/cid\/cir124","volume":"52","author":"R Kullar","year":"2011","unstructured":"Kullar R, Davis SL, Levine DP, Rybak MJ (2011) Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets. Clin Infect Dis 52(8):975\u2013981. https:\/\/doi.org\/10.1093\/cid\/cir124","journal-title":"Clin Infect Dis"},{"issue":"4","key":"4218_CR25","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1086\/324626","volume":"34","author":"R Leclercq","year":"2002","unstructured":"Leclercq R (2002) Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis 34(4):482\u2013492. https:\/\/doi.org\/10.1086\/324626","journal-title":"Clin Infect Dis"},{"issue":"2","key":"4218_CR26","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/JU.0000000000000509","volume":"203","author":"DJ Lightner","year":"2020","unstructured":"Lightner DJ, Wymer K, Sanchez J, Kavoussi L (2020) Best practice statement on urologic procedures and antimicrobial prophylaxis. J Urol 203(2):351\u2013356. https:\/\/doi.org\/10.1097\/JU.0000000000000509","journal-title":"J Urol"},{"key":"4218_CR27","doi-asserted-by":"publisher","unstructured":"Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, J Rybak M, Talan DA, Chambers HF (2011) Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 1;52(3):285\u201392. https:\/\/doi.org\/10.1093\/cid\/cir034","DOI":"10.1093\/cid\/cir034"},{"key":"4218_CR28","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/1471-2180-12-146","volume":"12","author":"S Monecke","year":"2012","unstructured":"Monecke S, Skakni L, Hasan R, Ruppelt A, Ghazal SS, Hakawi A, Slickers P, Ehricht R (2012) Characterisation of MRSA strains isolated from patients in a hospital in Riyadh. Kingdom of Saudi Arabia BMC Microbiol 12:146","journal-title":"Kingdom of Saudi Arabia BMC Microbiol"},{"key":"4218_CR29","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s41043-022-00305-x","volume":"41","author":"Y Nikmanesh","year":"2022","unstructured":"Nikmanesh Y, FooladyAzarnaminy A, Avishan P et al (2022) A Middle East systematic review and meta-analysis of prevalence and antibacterial substance susceptibility pattern in MRSA Staphylococcus aureus isolated from patients with cystic fibrosis. J Health Popul Nutr 41:26. https:\/\/doi.org\/10.1186\/s41043-022-00305-x","journal-title":"J Health Popul Nutr"},{"issue":"6","key":"4218_CR30","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1086\/605495","volume":"49","author":"JB Patel","year":"2009","unstructured":"Patel JB, Gorwitz RJ, Jernigan JA (2009) Mupirocin resistance. Clin Infect Dis 49(6):935\u2013941. https:\/\/doi.org\/10.1086\/605495","journal-title":"Clin Infect Dis"},{"issue":"10","key":"4218_CR31","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1093\/jac\/dkv169","volume":"70","author":"T Poovelikunnel","year":"2015","unstructured":"Poovelikunnel T, Gethin G, Humphreys H (2015) Mupirocin resistance: clinical implications and potential alternatives for the eradication of MRSA. J Antimicrob Chemother 70(10):2681\u20132692. https:\/\/doi.org\/10.1093\/jac\/dkv169","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"4218_CR32","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2217\/fmb.10.155","volume":"6","author":"RV Rasmussen","year":"2011","unstructured":"Rasmussen RV, Fowler VG, Skov R, Bruun NE (2011) Future challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSA. Future Microbiol 6(1):43\u201356","journal-title":"Future Microbiol"},{"issue":"8","key":"4218_CR33","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.tim.2014.04.007","volume":"22","author":"LS Redgrave","year":"2014","unstructured":"Redgrave LS, Sutton SB, Webber MA, Piddock LJ (2014) Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success. Trends Microbiol 22(8):438\u2013445. https:\/\/doi.org\/10.1016\/j.tim.2014.04.007","journal-title":"Trends Microbiol"},{"issue":"6","key":"4218_CR34","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1128\/JCM.42.6.2398-2402.2004","volume":"42","author":"G Sakoulas","year":"2004","unstructured":"Sakoulas G, Moise-Broder PA, Schentag J, Forrest A, Moellering RC, Eliopoulos GM (2004) Relationship of MIC and bactericidal activity to sensitivity of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol 42(6):2398\u20132402","journal-title":"J Clin Microbiol"},{"issue":"6","key":"4218_CR35","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3389\/fcimb.2016.00098","volume":"21","author":"MR Schroeder","year":"2016","unstructured":"Schroeder MR, Stephens DS (2016) Macrolide resistance in Streptococcus pneumoniae. Front Cell Infect Microbiol 21(6):98. https:\/\/doi.org\/10.3389\/fcimb.2016.00098","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"4218_CR36","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ijantimicag.2011.09.030","volume":"39","author":"S Stefani","year":"2012","unstructured":"Stefani S, Chung DR, Lindsay JA, Friedrich AW, Kearns AM, Westh H, Mackenzie FM (2012) Meticillin-resistant Staphylococcus aureus (MRSA): global epidemiology and harmonisation of typing methods. Int J Antimicrob Agents 39(4):273\u2013282. https:\/\/doi.org\/10.1016\/j.ijantimicag.2011.09.030","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"4218_CR37","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/jac\/dkm416","volume":"61","author":"E Tacconelli","year":"2008","unstructured":"Tacconelli E, De Angelis G, Cataldo MA, Pozzi E, Cauda R (2008) Does antibacterial substance exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. J Antimicrob Chemother 61(1):26\u201338. https:\/\/doi.org\/10.1093\/jac\/dkm416","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"4218_CR38","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.3390\/microorganisms11082086","volume":"11","author":"AK Thabit","year":"2023","unstructured":"Thabit AK, Alabbasi AY, Alnezary FS, Almasoudi IA (2023) An overview of antimicrobial resistance in Saudi Arabia (2013\u20132023) and the need for national surveillance. Microorganisms 11(8):2086","journal-title":"Microorganisms"},{"issue":"7","key":"4218_CR39","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1111\/1469-0691.12691","volume":"20","author":"S Tokajian","year":"2014","unstructured":"Tokajian S (2014) New epidemiology of Staphylococcus aureus infections in the Middle East. Clin Microbiol Infect 20(7):624\u2013628. https:\/\/doi.org\/10.1111\/1469-0691.12691","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"4218_CR40","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1128\/CMR.00134-14","volume":"28","author":"SY Tong","year":"2015","unstructured":"Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG (2015) Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev 28(3):603\u2013661","journal-title":"Clin Microbiol Rev"},{"key":"4218_CR41","unstructured":"WHO (2021) Antimicrobial Resistance. Retrieved 08Oct.2023, 2023, from https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance"},{"issue":"11","key":"4218_CR42","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.3855\/jidc.6976","volume":"9","author":"AA Zorgani","year":"2015","unstructured":"Zorgani AA, Elahmer O, Abaid A, Elaref A, Elamri S, Aghila E, Tubbal A (2015) Vancomycin susceptibility trends of methicillin-resistant Staphylococcus aureus isolated from burn wounds: a time for action. J Infect Dev Ctries 9(11):1284\u20131288","journal-title":"J Infect Dev Ctries"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04218-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04218-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04218-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T04:13:42Z","timestamp":1759983222000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04218-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["4218"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04218-4","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"type":"print","value":"0028-1298"},{"type":"electronic","value":"1432-1912"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"25 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}